These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1719540)

  • 1. A region of the insulin receptor important for ligand binding (residues 450-601) is recognized by patients' autoimmune antibodies and inhibitory monoclonal antibodies.
    Zhang B; Roth RA
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9858-62. PubMed ID: 1719540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding properties of chimeric insulin receptors containing the cysteine-rich domain of either the insulin-like growth factor I receptor or the insulin receptor related receptor.
    Zhang B; Roth RA
    Biochemistry; 1991 May; 30(21):5113-7. PubMed ID: 1645190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cysteine-rich domains of the insulin and insulin-like growth factor I receptors are primary determinants of hormone binding specificity. Evidence from receptor chimeras.
    Gustafson TA; Rutter WJ
    J Biol Chem; 1990 Oct; 265(30):18663-7. PubMed ID: 2170418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of insulin receptor dimerization domains in ligand binding, cooperativity, and modulation by anti-receptor antibodies.
    Surinya KH; Molina L; Soos MA; Brandt J; Kristensen C; Siddle K
    J Biol Chem; 2002 May; 277(19):16718-25. PubMed ID: 11875066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of an insulin receptor with an IGF-1 receptor loop exchange in the cysteine-rich region.
    Hoyne PA; Elleman TC; Adams TE; Richards KM; Ward CW
    FEBS Lett; 2000 Mar; 469(1):57-60. PubMed ID: 10708756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A monoclonal anti-peptide antibody reacting with the insulin receptor beta-subunit. Characterization of the antibody and its epitope and use in immunoaffinity purification of intact receptors.
    Ganderton RH; Stanley KK; Field CE; Coghlan MP; Soos MA; Siddle K
    Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):195-205. PubMed ID: 1280110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like and insulin-inhibitory effects of monoclonal antibodies for different epitopes on the human insulin receptor.
    Taylor R; Soos MA; Wells A; Argyraki M; Siddle K
    Biochem J; 1987 Feb; 242(1):123-9. PubMed ID: 2439067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of epitopes on the human insulin receptor reacting with rabbit polyclonal antisera and mouse monoclonal antibodies.
    Prigent SA; Stanley KK; Siddle K
    J Biol Chem; 1990 Jun; 265(17):9970-7. PubMed ID: 1693619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of monoclonal antibodies on human insulin receptor autophosphorylation, negative cooperativity, and down-regulation.
    Forsayeth JR; Montemurro A; Maddux BA; DePirro R; Goldfine ID
    J Biol Chem; 1987 Mar; 262(9):4134-40. PubMed ID: 2435731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of residues 485-599 from the human insulin receptor abolishes antireceptor antibody binding and influences tyrosine kinase activation.
    Sung CK; Wong KY; Yip CC; Hawley DM; Goldfine ID
    Mol Endocrinol; 1994 Mar; 8(3):315-24. PubMed ID: 8015549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping surface structures of the human insulin receptor with monoclonal antibodies: localization of main immunogenic regions to the receptor kinase domain.
    Morgan DO; Roth RA
    Biochemistry; 1986 Mar; 25(6):1364-71. PubMed ID: 2421765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of the monoclonal antibodies alpha IR-1 and alpha IR-3 with insulin and somatomedin-C receptors.
    Jacobs S; Cook S; Svoboda ME; Van Wyk JJ
    Endocrinology; 1986 Jan; 118(1):223-6. PubMed ID: 2416553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the insulin-like growth factor I (IGF I) epitopes recognized by monoclonal and polyclonal antibodies to IGF I.
    Cascieri MA; Bayne ML; Ber E; Green BG; Men GW; Chicchi GG
    Endocrinology; 1990 Jun; 126(6):2773-7. PubMed ID: 1693561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that human and porcine insulin differently affect the human insulin receptor: studies with monoclonal anti-insulin receptor antibodies.
    Sesti G; Marini MA; Montemurro A; Borboni P; Di Cola G; Bertoli A; De Pirro R; Lauro R
    J Endocrinol Invest; 1991 Dec; 14(11):913-8. PubMed ID: 1725292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ligand specificities of the insulin receptor and the insulin-like growth factor I receptor reside in different regions of a common binding site.
    Kjeldsen T; Andersen AS; Wiberg FC; Rasmussen JS; Schäffer L; Balschmidt P; Møller KB; Møller NP
    Proc Natl Acad Sci U S A; 1991 May; 88(10):4404-8. PubMed ID: 1852007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of V335 from the L2 domain of the insulin receptor results in a conformationally abnormal receptor that is unable to bind insulin and causes Donohue's syndrome in a human subject.
    George S; Johansen A; Soos MA; Mortensen H; Gammeltoft S; Saudek V; Siddle K; Hansen L; O'Rahilly S
    Endocrinology; 2003 Feb; 144(2):631-7. PubMed ID: 12538626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptors for insulin and insulin-like growth factor-I can form hybrid dimers. Characterisation of hybrid receptors in transfected cells.
    Soos MA; Whittaker J; Lammers R; Ullrich A; Siddle K
    Biochem J; 1990 Sep; 270(2):383-90. PubMed ID: 1698059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies to the human insulin receptor block insulin binding and inhibit insulin action.
    Roth RA; Cassell DJ; Wong KY; Maddux BA; Goldfine ID
    Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7312-6. PubMed ID: 6185950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a second ligand binding site of the insulin receptor.
    Hao C; Whittaker L; Whittaker J
    Biochem Biophys Res Commun; 2006 Aug; 347(1):334-9. PubMed ID: 16814253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies identify residues 199-216 of the integrin alpha2 vWFA domain as a functionally important region within alpha2beta1.
    Tuckwell DS; Smith L; Korda M; Askari JA; Santoso S; Barnes MJ; Farndale RW; Humphries MJ
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):485-93. PubMed ID: 10947963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.